Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
28
20
21
28
16
0
Crecimiento de los Ingresos (YoY)
47%
-5%
-25%
75%
--
-100%
Costo de los ingresos
12
7
5
6
4
0
Utilidad bruta
15
12
15
21
12
0
Venta, General y Administración
15
16
17
31
27
2
Investigación y Desarrollo
2
1
1
12
8
2
Gastos de Operación
18
18
19
47
38
5
Otras Ingresos (Gastos) No Operativos
0
0
0
0
0
--
Ingreso antes de impuestos
0
-3
2
-25
-26
-4
Gasto por Impuesto a la Renta
0
0
0
0
0
0
Ingreso Neto
0
-3
11
-25
-26
-4
Crecimiento de la Utilidad Neta
-100%
-127%
-144%
-4%
550%
-56%
Acciones en Circulación (Diluidas)
31.08
31.07
32.23
32.03
29.53
21.23
Cambio de Acciones (YoY)
0%
-4%
1%
8%
39%
-74%
EPS (Diluido)
-0.02
-0.12
0.36
-0.81
-0.9
-0.23
Crecimiento de EPS
-66%
-134%
-144%
-10%
291%
92%
Flujo de efectivo libre
1
0
0
-10
-18
-4
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
53.57%
60%
71.42%
75%
75%
0%
Margen de operación
-7.14%
-25%
-14.28%
-89.28%
-162.5%
0%
Margen de beneficio
0%
-15%
52.38%
-89.28%
-162.5%
0%
Margen de flujo de caja libre
3.57%
0%
0%
-35.71%
-112.5%
0%
EBITDA
-2
-5
-3
-23
-25
-4
Margen de EBITDA
-7.14%
-25%
-14.28%
-82.14%
-156.25%
0%
D&A para EBITDA
0
0
0
2
1
0
EBIT
-2
-5
-3
-25
-26
-4
Margen de EBIT
-7.14%
-25%
-14.28%
-89.28%
-162.5%
0%
Tasa de Impuesto Efectiva
0%
0%
0%
0%
0%
0%
Estadísticas clave
Cierre Anterior
$2.08
Precio de apertura
$2.08
Rango del día
$2.08 - $2.08
Rango de 52 semanas
$1.64 - $4.03
Volumen
34.0K
Volumen promedio
29.2K
EPS (TTM)
-0.03
Rendimiento de dividendos
--
Cap. de mercado
$64.6M
¿Qué es FORA?
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 1 full-time employees. The firm is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The firm provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. The company has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.